This company listing is no longer active
Igeamed Resultados de beneficios anteriores
Pasado controles de criterios 0/6
Igeamed's earnings have been declining at an average annual rate of -21.7%, while the Professional Services industry saw earnings growing at 10% annually. Revenues have been growing at an average rate of 6.8% per year.
Información clave
-21.7%
Tasa de crecimiento de los beneficios
n/a
Tasa de crecimiento del BPA
| Crecimiento de la industria Professional Services | 30.0% |
| Tasa de crecimiento de los ingresos | 6.8% |
| Rentabilidad financiera | -2.6% |
| Margen neto | -0.3% |
| Última actualización de beneficios | 31 Dec 2022 |
Actualizaciones de resultados anteriores recientes
Recent updates
Desglose de ingresos y gastosBeta
Cómo gana y gasta dinero Igeamed. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Dec 22 | 8 | 0 | 0 | 0 |
| 30 Sep 22 | 8 | 0 | 0 | 0 |
| 30 Jun 22 | 8 | 0 | 0 | 0 |
| 31 Mar 22 | 8 | 0 | 0 | 0 |
| 31 Dec 21 | 8 | 0 | 0 | 0 |
| 30 Sep 21 | 8 | 0 | 0 | 0 |
| 30 Jun 21 | 8 | 0 | 0 | 0 |
| 31 Mar 21 | 8 | 0 | 0 | 0 |
| 31 Dec 20 | 7 | 0 | 0 | 0 |
| 31 Dec 19 | 7 | 0 | 0 | 0 |
| 31 Dec 18 | 7 | 0 | 0 | 0 |
| 31 Dec 17 | 5 | 0 | 0 | 0 |
| 31 Dec 16 | 4 | 0 | 0 | 0 |
| 31 Dec 15 | 2 | 0 | 0 | 0 |
| 31 Dec 14 | 2 | 0 | 0 | 0 |
Ingresos de calidad: MED is currently unprofitable.
Margen de beneficios creciente: MED is currently unprofitable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: MED is unprofitable, and losses have increased over the past 5 years at a rate of 21.7% per year.
Acelerando crecimiento: Unable to compare MED's earnings growth over the past year to its 5-year average as it is currently unprofitable
Beneficios vs. Industria: MED is unprofitable, making it difficult to compare its past year earnings growth to the Professional Services industry (9.1%).
Rentabilidad financiera
Alta ROE: MED has a negative Return on Equity (-2.61%), as it is currently unprofitable.